| Edit |   |
|---|
| Product Name | Recombinant Human Bcl-xL (minus C-Terminus) Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 30 kDa, under reducing conditions. MW (theoretical): 24 kDa. The Recombinant Human Bcl-xL (minus C-Terminus) Protein from R&D Systems is derived from E. coli. The Recombinant Human Bcl-xL (minus C-Terminus) Protein has been validated for the following applications: Inhibition Activity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Inhibition Activity |
|---|
| Other Names | Apoptosis regulator Bcl-X, bcl2-L-1, BCL2-like 1, bcl-2-like protein 1, BCLXBCL2LBcl-X, bcl-xL, BclxL, BCL-XL/S, bcl-xS, BCLXS, DKFZp781P2092 |
|---|
| Gene, Accession, CAS # | BCL2L1, Gene ID: 598, Accession: CAA80661 |
|---|
| Catalog # | 894-BX-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Bcl-xL (minus C-Terminus) Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 17487982, 28825851, 30185627 |
|---|